Skip to main content
SpringerLink
Log in

The Effect of iNOS Inhibitors and Hyperbaric Oxygen Treatment in a Rat Model of Experimental Colitis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Aim Our aim was to investigate the effectiveness of aminoguanidine (AMG), an inducible nitric oxide synthase inhibitor, and hyperbaric oxygen (HBO) treatment in an experimental colitis model. Methods We induced colitis in rats. In the control group, we applied 2 ml serum physiologic intraperitoneally for 7 days. In the HBO group, 100% oxygen at 2.4 atm pressure was applied for 7 days. In the AMG group, 100 mg/kg AMG was applied intraperitoneally for 7 days. In the HBO + AMG group, HBO and AMG were applied, respectively. At the end of 7 days, rats were sacrificed and the distal 10 cm part of colon was examined macro- and microscopically. Results Severity of colitis and NO activities were reduced by AMG, HBO, and HBO + AMG application. There was histologically significant improvement, especially in the HBO + AMG group Conclusions Both HBO and AMG were significantly effective in preventing weight loss, reducing NO activities, and severity of colitis, when comparing HBO and AMG separately.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Pettersson S. Introduction: Inflammatory bowel disease: A complex systemic disease engaging multiple players outside the immune system. J Intern Med. 2008;263:574–576. doi:10.1111/j.1365-2796.2008.01973.x.

    Article  PubMed  CAS  Google Scholar 

  2. Pavlick KP, Laroux FS, Fuseler J, et al. Role of reactive metabolities of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med. 2002;33:311–322. doi:10.1016/S0891-5849(02)00853-5.

    Article  PubMed  CAS  Google Scholar 

  3. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet. 1994;344:859–861. doi:10.1016/S0140-6736(94)92831-2.

    Article  PubMed  CAS  Google Scholar 

  4. Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkley GB. Free radicals and other reactive oxygen metabolities in inflammatory bowel disease: Cause, consequence or epiphenomenon? Pharmacol Ther. 1992;53:375–408. doi:10.1016/0163-7258(92)90057-7.

    Article  PubMed  CAS  Google Scholar 

  5. Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:179–189. doi:10.1097/00054725-200305000-00006.

    Article  PubMed  Google Scholar 

  6. Singer II, Kawka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 1996;111:871–875. doi:10.1016/S0016-5085(96)70055-0.

    Article  PubMed  CAS  Google Scholar 

  7. Grisham MB, Specian RD, Zimmerman TE. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther. 1994;271:1114–1121.

    PubMed  CAS  Google Scholar 

  8. Rachmilewitz D, Karmeli F, Okon E, Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut. 1995;37:247–255. doi:10.1136/gut.37.2.247.

    Article  PubMed  CAS  Google Scholar 

  9. Rachmilewitz D, Karmeli F, Okon E. Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. Gastroenterology. 1995;109:98–106. doi:10.1016/0016-5085(95)90273-2.

    Article  PubMed  CAS  Google Scholar 

  10. Grim PS, Gottlieb LJ, Boddie A, Batson E. Hyperbaric oxygen therapy. JAMA. 1990;263:2216–2220. doi:10.1001/jama.263.16.2216.

    Article  PubMed  CAS  Google Scholar 

  11. Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S. Hyperbaric oxygen for perianal Crohn’s disease. J Clin Gastroenterol. 1994;19:202–205. doi:10.1097/00004836-199410000-00006.

    Article  PubMed  CAS  Google Scholar 

  12. Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS. Hyperbaric oxygen: A novel modality to ameliorate experimental colitis. Gut. 1998;43:512–518.

    Article  PubMed  CAS  Google Scholar 

  13. Colombel JF, Mathieu D, Bouault JM, et al. Hyperbaric oxygenation in severe perineal Crohn’s disease. Dis Colon Rectum. 1995;38:609–614. doi:10.1007/BF02054120.

    Article  PubMed  CAS  Google Scholar 

  14. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods. 2004;50:81–92. doi:10.1016/j.vascn.2003.12.002.

    Article  PubMed  CAS  Google Scholar 

  15. Yuan H, Ji WS, Wu KX, Jiao JX, Sun LH, Feng YT. Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis. World J Gastroenterol. 2006;12:4578–4581.

    PubMed  Google Scholar 

  16. Tsikas D. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: Appraisal of the Griess reaction in the l-arginine/nitric oxide area of research. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;851:51–70. doi:10.1016/j.jchromb.2006.07.054.

    Article  PubMed  CAS  Google Scholar 

  17. Butler AR, Flitney FW, Williams DL. NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist’s perspective. Trends Pharmacol Sci. 1995;16:18–22. doi:10.1016/S0165-6147(00)88968-3.

    Article  PubMed  CAS  Google Scholar 

  18. Takahashı T. Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol. 2003;38:421–430. doi:10.1007/s00535-003-1094-y.

    Article  PubMed  Google Scholar 

  19. Cuzzocrea S, McDonald MC, Mazzon E, et al. Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis. Eur J Pharmacol. 2000;406:127–137. doi:10.1016/S0014-2999(00)00623-3.

    Article  PubMed  CAS  Google Scholar 

  20. Zingarelli B, Cuzzocrea S, Szabo C, Salzman AL. Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther. 1998;287:1048–1055.

    PubMed  CAS  Google Scholar 

  21. Roediger WE, Lawson MJ, Nance SH, Radcliffe BC. Detectable colonic nitrite levels in inflammatory bowel disease-mucosal or bacterial mulfunction? Digestion. 1986;35:199–204.

    Article  PubMed  CAS  Google Scholar 

  22. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet. 1993;341:465–466. doi:10.1016/0140-6736(93)90211-X.

    Article  PubMed  CAS  Google Scholar 

  23. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Gut. 1995;36:718–723. doi:10.1136/gut.36.5.718.

    Article  PubMed  CAS  Google Scholar 

  24. Rachmilewitz D, Eliakim R, Ackerman Z, Karmeli F. Direct determination of colonic nitric oxide level—a sensitive marker of disease activity in ulcerative colitis. Am J Gastroenterol. 1998;93:409–412.

    PubMed  CAS  Google Scholar 

  25. Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MG. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol. 1995;268:G673–G684.

    PubMed  CAS  Google Scholar 

  26. Perner A, Andresen L, Normark M, et al. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis. Gut. 2001;49:387–394. doi:10.1136/gut.49.3.387.

    Article  PubMed  CAS  Google Scholar 

  27. Kankuri E, Hamalainen M, Hukkanen M, et al. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis. Scand J Gastroenterol. 2003;38:186–192. doi:10.1080/00365520310000681.

    Article  PubMed  CAS  Google Scholar 

  28. Pilichos CJ, Kouerinis IA, Zografos GC, et al. The effect of nitric oxide synthases inhibitors on inflammatory bowel disease in a rat model. In Vivo. 2004;18:513–516.

    PubMed  CAS  Google Scholar 

  29. Dudhgaonkar SP, Tandan SK, Kumar D, Raviprakash V, Kataria M. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats. Inflammopharmacol. 2007;15:188–195. doi:10.1007/s10787-007-1603-3.

    Article  CAS  Google Scholar 

  30. Nakamura H, Tsukada H, Oya M, et al. Aminoguanidine has both an anti-inflammatory effect on experimental colitis and a proliferative effect on colonic mucosal cells. Scand J Gastroenterol. 1999;34:1117–1122. doi:10.1080/003655299750024922.

    Article  PubMed  CAS  Google Scholar 

  31. Cuthbertson CM, Christophi C. Potential effects of hyperbaric oxygen therapy in acute pancreatitis. ANZ J Surg. 2006;76:625–630. doi:10.1111/j.1445-2197.2006.03793.x.

    Article  PubMed  Google Scholar 

  32. Christophi C, Millar I, Nikfarjam M, Muralidharan V, Malcontenti-Wilson C. Hyperbaric oxygen therapy for severe acute pancreatitis. J Gastroenterol Hepatol. 2007;22:2042–2046. doi:10.1111/j.1440-1746.2006.03380.x.

    Article  PubMed  Google Scholar 

  33. Alex J, Laden G, Cale AR, et al. Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: A prospective randomized double-blind trial. J Thorac Cardiovasc Surg. 2005;130:1623–1630. doi:10.1016/j.jtcvs.2005.08.018.

    Article  PubMed  Google Scholar 

  34. Marshall GT, Thirlby RC, Bredfeldt JE, Hampson NB. Treatment of gastrointestinal radiation injury with hyperbaric oxygen. Undersea Hyperb Med. 2007;34:35–42.

    PubMed  CAS  Google Scholar 

  35. Filntisis GA, Moon RE, Kraft KL, Farmer JC, Scher RL, Piantadosi CA. Laryngeal radionecrosis and hyperbaric oxygen therapy: Report of 18 cases and review of the literature. Ann Otol Rhinol Laryngol. 2000;109:554–562.

    PubMed  CAS  Google Scholar 

  36. Gürbüz AK, Elbüken E, Yazgan Y, Yildiz S. A different therapeutic approach in patients with severe ulcerative colitis: Hyperbaric oxygen treatment. South Med J. 2003;96:632–633. doi:10.1097/01.SMJ.0000074507.31006.79.

    Article  PubMed  Google Scholar 

  37. Gorgulu S, Yagci G, Kaymakcioglu N, et al. Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats. Dig Dis Sci. 2006;51:480–487. doi:10.1007/s10620-006-3159-2.

    Article  PubMed  CAS  Google Scholar 

  38. Demirtürk L, Ozel M, Yazgan Y, Buchman AL. Therapeutic efficacy of hyperbaric oxygenation in ulcerative colitis refractory to medical treatment. J Clin Gastroenterol. 2002;35:286–287. doi:10.1097/00004836-200209000-00021.

    Article  PubMed  Google Scholar 

  39. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J. Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol. 2001;33:337–339. doi:10.1097/00004836-200110000-00018.

    Article  PubMed  CAS  Google Scholar 

  40. Gulec B, Yasar M, Yildiz S, et al. Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol Res. 2004;53:493–499.

    PubMed  CAS  Google Scholar 

  41. Atug O, Hamzaoglu H, Tahan V, et al. Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E-induced experimental colitis. Dig Dis Sci. 2008;53:481–485. doi:10.1007/s10620-007-9956-4.

    Article  PubMed  CAS  Google Scholar 

  42. Akin ML, Gulluoglu BM, Uluutku H, et al. Hyperbaric oxygen improves healing in experimental rat colitis. Undersea Hyperb Med. 2002;29:279–285.

    PubMed  CAS  Google Scholar 

  43. Lin HC, Wan FJ, Wu CC, Tung CS, Wu TH. Hyperbaric oxygen protects against lipopolysaccharide-stimulated oxidative stress and mortality in rats. Eur J Pharmacol. 2005;508:249–254. doi:10.1016/j.ejphar.2004.12.021.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Internal Medicine, Department of Gastroenterology, Gulhane School of Medicine, Etlik, Ankara, Turkey

    Cemal Nuri Ercin, Zeki Yesilova & Ahmet Uygun

  2. Division of Internal Medicine, Department of Physiology, Gulhane School of Medicine, Etlik, Ankara, Turkey

    Ahmet Korkmaz

  3. Division of Internal Medicine, Department of Pathology, Gulhane School of Medicine, Etlik, Ankara, Turkey

    Ayhan Ozcan

  4. GATA Haydarpasa Training Hospital, Istanbul, Turkey

    Cagatay Oktenli

Authors
  1. Cemal Nuri Ercin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zeki Yesilova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmet Korkmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ayhan Ozcan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cagatay Oktenli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ahmet Uygun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cemal Nuri Ercin.

Additional information

Cemal Nuri Ercin and Zeki Yesilova contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ercin, C.N., Yesilova, Z., Korkmaz, A. et al. The Effect of iNOS Inhibitors and Hyperbaric Oxygen Treatment in a Rat Model of Experimental Colitis. Dig Dis Sci 54, 75–79 (2009). https://doi.org/10.1007/s10620-008-0498-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0498-1

Keywords

Search

Navigation